SEC
SlamSEC
SearchBrowseEarnings

Immunocore Holdings plc

Nasdaq:IMCR
Biological Products, (No Diagnostic Substances)·OXFORDSHIRE, X0
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Credit & Agreementsmaterial agreements · debt obligations

Credit & Agreements (8-K)

3 shown
FiledDescription
11/8/24
1.02
Agreement Terminated
→
5/28/24
1.01
Material Agreement
→
2/2/24
1.012.03
Material Agreement · New Debt Obligation
→

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.